India Battles Rising Drug-Resistant TB Emergency

India is grappling with a significant public health crisis due to drug-resistant tuberculosis (DR-TB), a form of the disease that is proving increasingly difficult to treat. Despite a general decrease in TB incidence, an estimated 100,000 cases continue to go undetected each year, facilitating silent community transmission. This situation is compounded by India's substantial share of the global DR-TB burden, with 1.3-1.5 lakh new cases emerging annually, according to WHO 2025 data.

Preparedness for DR-TB remains a significant challenge across the nation. Inconsistent access to advanced diagnostic technologies, especially in rural and remote areas, leads to delays in identifying drug resistance. This often results in patients being placed on less effective first-line treatments, inadvertently spreading resistant strains. Furthermore, geographic and socioeconomic disparities heavily influence access to specialized care and consistent monitoring, with many patients facing arduous journeys and financial strain.

The treatment for DR-TB itself is arduous, involving toxic drug regimens with severe side effects, lower cure rates, and higher mortality. While newer, all-oral regimens like BPaLM are being introduced, their accelerated and equitable scale-up is critical. Robust support systems, including mental health care, nutritional aid, and income protection, are essential for patient adherence and recovery. Improving data collection, particularly from the private sector, is vital for understanding the true scope of the crisis.

Addressing DR-TB requires decisive political and financial commitment. Investments in diagnostics, second-line drugs, community-based care, and psychosocial services are imperative. Universal upfront drug-resistance testing for all TB patients must become standard practice. Integrating the private sector more effectively, mandating common standards, and expanding successful public-private partnerships can improve overall access to quality DR-TB care.

Breaking the cycle of transmission necessitates active case finding, contact tracing, and treating latent TB infection. Survivor-centered care models that incorporate mental health, nutrition, and income support are crucial. Combating the stigma associated with DR-TB through sustained public awareness campaigns is equally vital to encourage timely care-seeking and ensure this health emergency receives the urgent attention it deserves.